Vu, Victoria
Barsyte-Lovejoy, Dalia
2019-08-05
<p>Overexpressing HTT in neuronal cells.</p>
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
https://doi.org/10.5281/zenodo.3361015
oai:zenodo.org:3361015
Zenodo
https://doi.org/10.5281/zenodo.3361014
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
HTT, huntingtin, Huntington's Disease
Overexpressing HTT in neuronal cells
info:eu-repo/semantics/other